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Abstract
Background:  Nesidioblastosis  is  a  rare  cause  of  endocrine  disease  which  represents  between
0.5% and  5%  of  cases.  This  has  been  associated  with  other  conditions,  such  as  in  patients  previ-
ously treated  with  insulin  or  sulfonylurea,  in  anti-tumour  activity  in  pancreatic  tissue  of  patients
with insulinoma,  and  in  patients  with  other  tumours  of  the  Langerhans  islet  cells.  In  adults  it  is
presented  as  a  diffuse  dysfunction  of    cells  of  unknown  cause.
Clinical  case: The  case  concerns  46  year-old  female,  with  a  history  of  Sheehan  syndrome  of
ﬁfteen years  of  onset,  and  with  repeated  events  characterised  with  hypoglycaemia  in  the  last
three years.  Body  scan  was  performed  with  octreotide,  revealing  an  insulinoma  in  the  pancreatic
region. A  distal  pancreatectomy  was  performed  on  the  patient.  The  study  reported  a  pancreatic
fragment  8.5  cm  ×  3  cm  ×  1.5  cm  with  abnormal  proliferation  of  pancreatic  islets  in  groups  of
varying size,  some  of  them  in  relation  to  the  ductal  epithelium.  Histopathology  study  was
showed positive  for  chromogranin,  conﬁrmed  by  positive  synaptophysin,  insulin  and  glucagon,
revealing islet  hyperplasia  with  diffuse  nesidioblastosis  with  negative  malignancy.  The  patient
is currently  under  metabolic  control  and  with  no  remission  of  hypoglycaemic  events.
DOI of original article: http://dx.doi.org/10.1016/j.circir.2015.05.020
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Conclusions:  Nesidioblastosis  is  a  disease  of  difﬁcult  diagnosis  should  be  considered  in  all  cases
of failure  to  locate  an  insulinoma,  as  this  may  be  presented  in  up  to  4%  of  persistent  hyperin-
sulinaemic hypoglycaemia.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Resumen
Antecedentes:  La  nesidioblastosis  constituye  una  causa  rara  de  enfermedad  endocrina,  que
representa entre  0.5%  al  5%  de  los  casos.  Se  ha  descrito  en  asociación  con  otras  condiciones,
como en  pacientes  previamente  tratados  con  insulina  o  sulfonilurea,  en  tejido  pancreático  no
tumoral de  pacientes  con  insulinoma,  y  en  pacientes  con  otros  tumores  de  las  células  de  los
islotes de  Langerhans.  En  el  adulto  se  presenta  como  una  disfunción  difusa  de  las  células  , de
causa desconocida.
Caso  clínico: Femenina  de  46  an˜os,  con  síndrome  de  Sheehan  de  quince  an˜os  de  evolución
y en  los  últimos  tres  an˜os,  presentó  eventos  repetidos  caracterizados  de  hipoglucemia.  Se
realizó rastreo  corporal  con  octreótide,  revelando  captación  de  región  pancreática  en  relación
con insulinoma.  Se  sometió  a  pancreatectomía  distal.  El  informe  fue  de  un  fragmento  de  pán-
creas de  8.5  ×  3  ×  1.5  cm  con  proliferación  anormal  de  islotes  pancreáticos  en  grupo  de  taman˜o
variable, algunos  de  ellos  en  relación  al  epitelio  ductal.  El  estudio  histopatológico  mostró
positividad  para  cromogramina,  sinaptosina,  insulina  y  glucagón  en  islotes  hiperplásicos,  que
conﬁrmó Nesidioblastosis  difusa  del  adulto,  negativo  a  malignidad.  Actualmente  la  paciente  se
encuentra con  adecuado  control  metabólico,  y  con  remisión  de  los  eventos  de  hipoglucemia.
Conclusiones:  La  nesidioblastosis  es  una  patología  de  difícil  diagnóstico,  debe  considerarse  en
todos los  casos  en  donde  no  se  logre  la  localización  de  un  insulinoma,  ya  que  esta  puede  estar
presente hasta  en  el  4%  de  las  hipoglucemias  hiperinsulinémicas  persistentes.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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In  1938  George  Laidlaw  coined  the  term  nesidioblastosis  to
refer  to  the  neoformation  of  Langerhans  islet  cells  from  the
exocrine  pancreatic  ductal  epithelium;  however,  it  was  not
until  1971  that  Yakovac  used  this  term  to  describe  lesions
of  the  endocrine  pancreas  in  infants,  when  he  reported  12
cases  of  children  with  persistent  hyperinsulinaemic  hypogly-
caemia.  At  present,  the  nesidioblastosis  of  the  pancreas  in
adults  is  deﬁned  as  changes  in  the  endocrine  pancreas  char-
acterised  by  the  abnormal  proliferation  of  the  pancreatic
islet  cells  that  affect  the  gland  in  a  diffuse  manner  budding
off  from  the  ductal  epithelium  and  causing  persistent  hyper-
insulinaemic  hypoglycaemia  in  absence  of  insulinoma.1--4
Clinical case
A  46-year-old  female  with  15  years  history  of  Sheehan’s
syndrome  evolution,  treated  with  100  mcg  of  levothyroxine
and  5  mg  of  prednisone/24  h.  She  went  to  hospital  because
of  exacerbation  of  a  3-year  history  of  a  clinical  condi-
tion  of  repeated  events  characterised  by  nausea,  dizziness,
diaphoresis,  palpitations,  and  loss  of  alertness  associated
m
n
eith  hypoglycaemia,  which  reverted  with  the  intake  of  sim-
le  sugars.
On  physical  examination  she  presented  blood  pressure
f  120/70  mmHg,  heart  rate  of  70  bpm,  body  weight  of
0  kg,  height  was  155  cm,  BMI  of  29  kg/m2; and  the  rest
f  the  physical  exploration  was  within  normal  parameters.
he  laboratory  studies  reported  haemoglobin  was  14.2  g/dl;
aematocrit,  39.4%;  platelet,  287,000;  leukocytes,  9300;
lucose,  69  mg/dl;  urea,  28  mg/dl;  creatinine,  0.7  mg/dl;
ree  T4,  1.22  ng/dl,  and  thyroid-stimulating  hormone  was
.2  UI/ml.  A  fasting  test  was  performed  which  showed  the
resence  of  endogenous  hyperinsulinism  with  blood  sugar
evels  of  52  mg/dl  in  absence  of  adrenergic  and/or  neurogly-
openic  symptoms,  insulinaemia  of  7.61  U/ml,  C  peptide  of
.5  ng/dl,  and  proinsulin  of  5.8  pmol/l  at  72  h.
Tomography  imaging  studies  did  not  show  evidence  of  dis-
ase  in  the  pancreas  (Fig.  1).  A  body  scan  performed  with
ctreotide  showed  pancreatic  capture  towards  middle  line;
nd  the  rest  of  the  scan  showed  no  evidence  of  lesions  that
ay  suggest  metastatic  activity  (Fig.  2).
From  the  imaging  studies  ﬁndings,  the  patient  was  sub-
itted  to  a  pancreatic  exploration;  however,  no  suspicious
odular  lesions  were  located  on  palpation  or  macroscopic
xamination  and  the  pancreatic  gland  presented  normal
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Figure  1  Computed  axial  tomography  scan  showing  xan-
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Figure  3  Chromogranin,  with  increased  number  of  Langer-
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thogranulomatous  process  in  greater  curvature  of  the  stomach.
haracteristics,  and  therefore  a  distal  pancreatectomy  at
he  level  of  the  mesenteric  vessels  was  performed.
The  glucose  level  stayed  normal.  During  the  immediate
ostoperative  period  the  patient  presented  glucose  con-
entrations  in  venous  blood  of  100  and  130  mg/dl,  which
rompted  the  administration  of  rapid  insulin.
Histopathological  study  and  macroscopic  examination
eported  a  pancreatic  fragment  of  8.5  cm  ×  3  cm  ×  1.5  cm,
f  yellow  colour,  with  a  trabecular  surface,  with  areas  of
reater  congestion.  Microscopic  examination  showed  abnor-
al  proliferation  of  pancreatic  islets  disposed  in  groups  of
ariable  sizes,  some  of  which  were  related  to  the  ducal
m
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igure  2  Octreoscan  shows  uptake  site  in  anatomical  projection  o
he scanning  did  not  evidence  lesions  that  may  suggest  metastatic  aans islets  (more  than  10  lobes)  with  tendency  to  converge  in  a
uct.
pithelium  and  forming  hyperchromatic,  enlarged  ductal
omplexes  with  ample  clear  cytoplasm.  Immunohistochem-
stry  revealed  that  the  hyperplastic  islets  were  positive
or  chromogranin  A  with  peripheral  concentration,  diffuse
ynaptophysin,  glucagon  in  the  periphery  of  the  islets  and
n  the    cells,  and  insulin  of  diffuse  form  in  the  intra-
cinar  cells  (Figs.  3  and  4).  Clinical,  radiological,  histologic
nd  immunohistochemical  criteria  were  collected  to  deter-
ine  the  diagnosis  of  diffuse  nesidioblastosis  in  the  adult,
egative  for  malignancy.  At  present,  the  patient  presents
 good  metabolic  control,  with  remission  of  the  hypogly-
aemia  events.
f  pancreatic  region  towards  the  middle  line  at  48  h;  the  rest  of
ctivity.
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ticosteroids  administered  for  her  Sheehan’s  syndrome.6,10,13Figure  4  Insulin  10×.  Islets  with  diffuse  positivity  are
observed.
Discussion
The  persistent  hyperinsulinaemic  hypoglycaemia  is  caused
by  the  alteration  in  the  pancreatic    cell  function,  mainly
caused  by  nesidioblastosis  in  newborns.  In  adults,  most  of
the  hyperinsulinaemic  hypoglycemia  cases  are  caused  by  iso-
lated  insulinomas,  the  nesidioblastosis  being  responsible  for
only  0.5--5%  of  the  cases.  The  ﬁrst  case  of  nesidioblastosis
in  an  adult  was  reported  in  1975.2,3
Several  genetic  abnormalities  have  been  identiﬁed  as
associated  with  the  pathogenesis  of  persistent  hyperin-
sulinaemic  hypoglycaemia  in  infancy,  the  most  frequent
being  mutations  of  the  genes  ABCC8  (SUR1) and  KCNJ11
(Kir6.2),  in  the  chromosome  11  short  arm,  which  encode
the  sub-units  of  ATP-sensitive  potassium  channels  in  the
cell  membrane  ,  producing  a  permanent  insulin  secre-
tion.  Also,  6  other  possible  causes  have  been  identiﬁed
recently,  such  as  loss  of  function  due  to  mutations  in  glucoki-
nase  (GCK),  glutamate  dehydrogenase  (GLUD1),  hydroxyacyl
CoA  dehydrogenase  (HADH1),  plasmatic  membrane  pyruvate
transporter  (SLC16A1),  mitochondrial-uncoupling  protein
(UCP2),  and  hepatocyte  nuclear  factors  (HNF4a).  Although
it  is  true  that  these  alterations  have  not  been  reported  in
adults,  it  is  important  to  note  that  mutations  such  as  GLUD1,
GCK,  SLC16A1,  and  some  slight  ABCC8  and  KCNJ11  mutations
may  not  be  detected  during  childhood  but  may  be  recognised
for  the  ﬁrst  time  during  adulthood,  as  it  is  not  infrequent
that  subjects  are  diagnosed  during  childhood  or  even  after
it.5,6
The  morphological  substrate  of  these  molecular  changes
can  appear  in  children  as  diffuse  cell  hypertrophy    (diffuse
nesidioblastosis)  in  60%  or  as  focal  cell  hypertrophy    (focal
nesidioblastosis)  in  40%;  however,  this  last  presentation  has
not  been  described  in  adults.1,2
In  adults,  the  nesidioblastosis  was  initially  described
as  being  associated  with  other  diseases,  such  as
Zollinger--Ellison  syndrome,  multiple  endocrine  adeno-
matosis,  cell  adenomatosis  ,  Von  Hippel--Lindau  disease,
cystic  ﬁbrosis,  orbital  lymphoma  with  hypopituitarism
and  adrenal  insufﬁciency,  familial  adenomatous  polyposis,
hypergastrinaemia  and  pancreatic  polypeptidemia,  in
t
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on-tumour  pancreatic  tissue  of  patients  with  insulinomas.
ith  the  increase  of  bariatric  surgery,  particularly  the
astric  bypass,  and  although  the  pathophysiological  effect
f  this  is  still  unclear,  it  has  been  observed  that  in  these
atients  higher  levels  of  polypeptide  with  trophic  effect  on
he    cell,  as  the  glucagon-like  peptide  1,  contributes  to
he  pancreatic  cellular  hypertrophy    and,  consequently,  to
he  islets  hyperfunction,  which  results  in  the  postprandial
ypoglycaemia.2,7,8
It  is  not  clinically  or  biochemically  possible  to  dis-
inguish  the  nesidioblastosis  from  the  insulinoma,  and
t  is  necessary  that  both  clinicians  and  pathologists
ork  closely  together  to  determine  the  diagnosis.  It  is
lso  essential  to  rule  out  the  diagnosis  of  insulinoma
eforehand.3
Some  patients  present  hypoglycaemia  symptoms,  pre-
ominantly  postprandial,  when  not  fasting,  as  it  usually
ccurs  in  patients  with  persistent  hyperinsulinaemic  hypo-
lycaemia  secondary  to  insulinoma.  However,  most  of  the
atients  present  typical  hypoglycaemia  symptoms  (Whip-
le’s  triad);  adrenergic  symptoms,  such  as  diaphoresis,
alpitations,  anxiety,  tremor,  sensation  of  hunger,  and  neu-
oglycopaenia  symptoms,  such  as  confusion,  blurred  vision,
mnesia,  and  loss  of  consciousness.2
The  ideal  reference  test  to  evaluate  the  presence  of
ypoglycaemia  is  the  72  h fast  period,  with  the  aim  of  assess-
ng  the  role  of  insulin  in  the  genesis  of  hypoglycaemia.  In
ur  patient,  this  test  evidenced  the  presence  of  endoge-
ous  hyperinsulinism,  which  prompted  the  performance  of
maging  studies  to  localise  the  lesion.
Computed  axial  tomography  did  not  demonstrate  the
resence  of  a  lesion;  therefore,  an  octreoscan  was  then
erformed,  and  the  presence  of  an  image  suggestive  of  a
esion  in  the  pancreatic  neck,  with  high  levels  of  contrast
ptake  was  shown.  However,  clinically,  the  patient  pre-
ented  Whipple’s  triad  with  hypoglycaemia  symptoms,  low
evel  of  blood  glucose,  which  responded  to  intravenous  glu-
ose  administration,  and  increased  serum  levels  of  insulin.
his  generated  the  clinical  suspicion  that  the  patient  had  an
nsulinoma.  On  the  possibility  of  the  probable  presence  of
nsulinoma,  the  protocol  for  the  resection  of  the  lesion  was
tarted.6,9,10
Surgical  resection  is  considered  to  be  the  treatment
f  choice  for  nesidioblastosis.  However,  the  extension  of
t  is  still  controversial.11,12 Most  surgeons  perform  distal
ancreatectomy;  some  have  even  conducted  90--95%  pan-
reatectomy;  but,  according  to  some  authors,  a  subtotal
ancreatectomy  is  associated  with  insulin-dependent  dia-
etes  and  exocrine  pancreatic  dysfunction  in  40%;  with
esection  of  60%  of  the  pancreas,  8%  of  the  patients  will
resent  insulin-dependent  diabetes  mellitus,  but  with  higher
ecurrence  rates  of  hypoglycaemia.  If  surgery  is  not  success-
ul  or  is  contraindicated,  drugs  such  as  diazoxide,  octreotide
r  verapamil  can  be  used.  Our  patient  was  surgically  man-
ged  with  a  distal  pancreatectomy,  resecting  the  70%  of
he  pancreas,  and  the  result  was  secondary  diabetes  mel-
itus.  She  stayed  within  the  8%  of  the  cases  reported  by  the
edical  bibliography,  aggravated  by  the  treatment  with  cor-In  the  histopathological  study,  the  macroscopic  presenta-
ion  of  the  pancreas  is  normal;  the  ﬁnding  varies  among  the
atients  and  up  to  the  third  part  of  the  cases,  the  changes
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re  minimum.  For  this  reason,  it  is  difﬁcult  to  differentiate
hem  from  normal  pancreas.11,14,15
Other  ﬁndings  in  patients  with  nesidioblastosis  have
een  reported,  such  as  an  insulin-like  growth  factor  type  2
ver-expression,  type  1  insulin-like  growth  factor  receptor,
ransforming  growth  factor    3,  and  peliosis-type  vascu-
ar  ectasia.  This  is  very  useful  for  diagnosis.  In  our  case,  we
ound  hyperplasia  of  the  Langerhans  islets  with  no  tumour,
uctal  epithelium  hyperplasia,  excluding  macroscopic  and
icroscopic  diagnosis  of  insulinoma,  with  islets  of  irregu-
ar  shapes  and  enlarged  in  number  and  size.  All  the  above,
llowed  us  to  conclude  that  the  diagnosis  was  diffuse  nesid-
oblastosis  in  adult.2,10,11,16
onclusion
esidioblastosis  is  a  disease  of  difﬁcult  diagnosis  that  should
e  considered  in  all  the  cases  where  it  is  not  possible  to  ﬁnd
nsulinoma,  as  this  may  be  presented  in  up  to  4%  of  persis-
ent  hyperinsulinaemic  hypoglycaemia.  Early  identiﬁcation
nd  diagnosis  play  an  essential  role  in  the  prognosis  of  the
isease.
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